Report Highlights
Here are the key highlights from the report:
- Feed Scope: Companies engaged in R&D for developing medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of cardiac and vascular disorders.
Companies included in the report
Companies engaged in R&D for developing medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of cardiac and vascular disorders.Top Cardiac and Vascular Disorders Companies
The top 3 companies in Cardiac and Vascular Disorders are Withings, AliveCor and iRhythm Tech.Recent Investments
Recent noteworthy Investments in Cardiac and Vascular Disorders sector include:- $411M, Series A round in Verdiva Bio on Jan 09, 2025
- $300M, Series A round in Kardigan on Jan 13, 2025
- $287M, Series D round in CORXEL on Jan 22, 2026
Top Acquisitions
- Notable acquisitions in the Cardiac and Vascular Disorders sector include AVVie being acquired by P&F Products and Features on Aug 05, 2026, Endospan acquired by Artivion on May 18, 2026 and Cardios acquired by Cardioline on May 05, 2026.
Report Preview
__SrgFCcHNsK6MUHpNmUQFk.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
__NqI2y3jE93lF27h_QWOlg.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
__1y526bokJCPkBF6PAbxq8.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
__LliivjYYWe4RMq8tcOhGu.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
